Evidence map›Paper›PMID 42306710›Full record

ArticleJournal of thoracic disease2026

AHNAK promotes oxidative stress and inflammatory responses in chronic obstructive pulmonary disease by activating the Notch pathway.

Chunhui Zhang, Yu Liu

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chunhui ZhangDepartment of Pulmonary and Critical Care Medicine, Fujian Provincial Geriatric Hospital, Fuzhou, China.
Yu LiuDepartment of Pulmonary and Critical Care Medicine, Fujian Provincial Geriatric Hospital, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a common respiratory disease with high mortality. AHNAK nucleoprotein (AHNAK) is predicted to be highly expressed in COPD; however, its role remains unclear. This study aimed to investigate the role of AHNAK in COPD and the underlying molecular mechanism. A549 cells were treated with cigarette smoke extract (CSE) as an

Indexed as

AHNAK nucleoprotein (AHNAK)Chronic obstructive pulmonary disease (COPD)inflammationNotch pathwayoxidative stress

Identifiers

PMID42306710
PMCPMC13266837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.